2020 Core Competencies in the Management of Advanced Pulmonary Hypertension and Right Ventricular Failure


←  BACK TO 2020 ACADEMIES

When & Where

Tuesday, April 21, 2020
8:15 AM – 5:40 PM

511, Palais des Congrès
Montréal, Canada

Chair

Colin Church, MRCP
Golden Jubilee National Hospital, Glasgow, UK
 

Co-Chair

Ryan J. Tedford, MD
Medical University of South Carolina, Charleston, SC, USA

 
Paul Corris, MB, FRCP, Freeman Hospital, University of Newcastle, Newcastle, UK
Colin Church, MRCP, Golden Jubilee National Hospital, Glasgow, UK
Robert Frantz, MD, Mayo Clinic, Rochester, MN, USA
Adaani Frost, MD, Houston Methodist Lung Center, Houston, TX, USA
Wendy Gin-Sing, Hammersmith Hospital, London, UK
Mardi Gomberg-Maitland, MD, MSc, University of George Washington Hospital, Washington, DC, USA
John Granton, MD, Toronto General Hospital, Toronto, Canada
Marco Guazzi, MD, PhD, University of Milano, Milan, Italy
Brian A. Houston, MD, The Medical University of South Carolina, Charleston, SC, USA
Steven Hsu, MD, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Dana McGlothlin, MD, Kaiser Permanente San Francisco, San Francisco, CA, USA
Steven Nathan, MD, Inova Fairfax, Falls Church, VA, USA
Joanna Pepke-Zaba, PhD, FRCP, Royal Papworth Hospital, Cambridge, UK
Ioana Preston, MD, Tufts Medical Centre, Boston, MA, USA
Ryan J. Tedford, MD, Medical University of South Carolina, Charleston, SC, USA
Jean Luc Vachiery, MD, Erasme University Hospital, Brussels, Belgium
Pulmonary hypertension (PH) is a life-threatening condition commonly encountered in patients with advanced heart and lung disease. Despite significant advances in the field, patients with PH are complex, their management is challenging, and their survival remains limited. The educational goals of this activity are to provide a concise review of clinical knowledge and essential professional skills to facilitate best practice of surgical and medical aspects involved in the care of patients with pulmonary vascular disease and right ventricular dysfunction, including those with advanced heart and lung disease.
This course is primarily designed to be of benefit for clinicians and allied health professionals who are in the early stages of their careers, or who are in training and/or are part of a new program, or desire an update on the current state of the field. The information presented covers core competencies and is intended to provide a strong foundation of the overarching principles of pulmonary hypertension, rather than as a detailed update for those who are already proficient experts in the field.
At the conclusion of this meeting, participants will have improved competence and professional performance in their ability to:
 
  1. Discuss the definitions, diagnosis, and classification of patients with pulmonary hypertension
  2. Recognize the indication and use of available pulmonary hypertension specific therapies
  3. Understand the epidemiology, pathophysiology, and management principles for the five World Health Organization pulmonary hypertension groups, including patients with advanced heart and lung failure
  4. Recognize the role of the right ventricle in pulmonary hypertension and understand the management principles for right ventricular failure and end-stage PH
  5. Review perioperative considerations for patients with pulmonary hypertension undergoing surgery, including thoracic transplantation, VAD implantation, and pregnancy.
Physicians
Accreditation Statement – The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement – ISHLT designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISHLT. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 7.25 contact hours for nurses and 3.75 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Current guidelines state that participants in CME activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentations or service as Chair/Planner. These disclosures will be distributed at the meeting. Additionally, all speakers have been asked to verbally disclose at the start of their presentation if a product they are discussing is not labeled for the use under discussion or is still investigational.